中医临床处方饮片用量调研报告(内科)

Studies and reports of Chinese cut crude drug's dosage in clinical prescription of(section of medical department)

目的:调研中医内科临床处方饮片用量,为制定中药饮片用量标准提供依据。方法:在全国不同区域,选取18个省市的21家医院,采用分层抽样和简单随机抽样相结合的方法,收集门诊中医内科内服汤剂处方269 882张,构建中药饮片用量数据库,基于Weka数据挖掘软件进行统计分析。结果:明确了300味药物的中医内科临床用药频次、相应的用量区间、及其与《中国药典》规定用量不相符合的155味药物具体的用量,大多数药物的临床用量区间为(3-6],(9-12],(12-15],(18-21]4个区间,具体集中在3,6,10,12,15,20 g等用量上。结论:《中国药典》部分中药的规定用量与中医内科临床实际用量严重不符,需要修订,并为制定用量新标准提供了依据。

Objective： Study the actual dosage of clinical prescription in medical department of traditional Chinese medicine （TCM）, and offer the consummate data for formulating the dosage standard of Chinese cut crude drug. Method： We made use of the methods of stratified sampling and random sampling to investigate 269 882 broth prescriptions of Medical Department of TCM in 21 various hospitals, 18 provinces, and constructed the database, then applied Weka KDD software to analyze. Result： We identified the frequency and clinical dosage intervals of 300 drugs, and the practical dosage of 155 drugs which dose has difference between in the actuality and in the pharmacopoeia. Most of drug＇s dosage centralized the four intervals ： （3-6 ], （9-12], （ 12-15 ], （ 18-21 ], and the concrete dosage were 3, 6, 10, 12, 15, 20 g, etc. Conclusion： The dosages in the pharmacopoeia are not coincided with the practical dosages in internal medicine, and demand to revise. This paper will offer the consummate data for formulating the new dosage standard.